Beresniak A - Search Results

1

Direct cost-modeling of rheumatoid arthritis according to disease activity categories in France.

Beresniak A, Gossec L, Goupille P, Saraux A, Bamberger M, Bregman B, Dupont D. Beresniak A, et al. J Rheumatol. 2011 Mar;38(3):439-45. doi: 10.3899/jrheum.100589. Epub 2010 Dec 1. J Rheumatol. 2011. PMID: 21123324

2

Advantages and limitations of utility assessment methods in rheumatoid arthritis.

Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G. Beresniak A, et al. J Rheumatol. 2007 Nov;34(11):2193-200. Epub 2007 Oct 15. J Rheumatol. 2007. PMID: 17937471

3

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis.

Russell A, Beresniak A, Bessette L, Haraoui B, Rahman P, Thorne C, Maclean R, Dupont D. Russell A, et al. Among authors: beresniak a. Clin Rheumatol. 2009 Apr;28(4):403-12. doi: 10.1007/s10067-008-1060-4. Epub 2008 Dec 17. Clin Rheumatol. 2009. PMID: 19089488

4

Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France.

Saraux A, Gossec L, Goupille P, Bregman B, Boccard E, Dupont D, Beresniak A. Saraux A, et al. Among authors: beresniak a. Rheumatology (Oxford). 2010 Apr;49(4):733-40. doi: 10.1093/rheumatology/kep434. Epub 2010 Jan 16. Rheumatology (Oxford). 2010. PMID: 20081224

5

Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.

Beresniak A, Ariza-Ariza R, Garcia-Llorente JF, Ramirez-Arellano A, Dupont D. Beresniak A, et al. Int J Inflam. 2011;2011:727634. doi: 10.4061/2011/727634. Epub 2011 Jun 28. Int J Inflam. 2011. PMID: 21785694 Free PMC article.

6

Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach.

Cimmino MA, Leardini G, Salaffi F, Intorcia M, Bellatreccia A, Dupont D, Beresniak A. Cimmino MA, et al. Among authors: beresniak a. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):633-41. Epub 2011 Aug 31. Clin Exp Rheumatol. 2011. PMID: 21813056

7

A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger.

Beresniak A, Bertherat E, Perea W, Soga G, Souley R, Dupont D, Hugonnet S. Beresniak A, et al. Bull World Health Organ. 2012 Jun 1;90(6):412-417A. doi: 10.2471/BLT.11.086009. Epub 2012 Jan 20. Bull World Health Organ. 2012. PMID: 22690030 Free PMC article.

8

Cost-effectiveness of mitral valve repair versus replacement by biologic or mechanical prosthesis.

Beresniak A, Sabatier B, Achouh P, Menasché P, Fabiani JN. Beresniak A, et al. Ann Thorac Surg. 2013 Jan;95(1):98-104. doi: 10.1016/j.athoracsur.2012.08.005. Epub 2012 Oct 11. Ann Thorac Surg. 2013. PMID: 23063201

9

Interest of modelling in rheumatoid arthritis.

Beresniak A, Dupont DM, Becker JC, Merkesdal S. Beresniak A, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S96-101. Epub 2012 Oct 18. Clin Exp Rheumatol. 2012. PMID: 23078913 Review.

10

Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.

Beresniak A, Baerwald C, Zeidler H, Krüger K, Neubauer AS, Dupont D, Merkesdal S. Beresniak A, et al. Clin Exp Rheumatol. 2013 May-Jun;31(3):400-8. Epub 2013 Mar 4. Clin Exp Rheumatol. 2013. PMID: 23464803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters